{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T11:36:11Z","timestamp":1792064171147,"version":"4.4.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T00:00:00Z","timestamp":1644969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T00:00:00Z","timestamp":1644969600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Iron stores, estimated as ferritin levels, and type 2 diabetes (T2D) have been associated previously, while findings regarding coronary heart disease (CHD) and cerebrovascular disease (CEVD) are still inconclusive. No study has focused on simultaneous evaluation of associations between iron stores and the above cardiometabolic diseases (CMD) in the same population. We aim to evaluate the association between serum ferritin and risk of T2D, CHD and CEVD in Scottish population over a wide range of ferritin levels.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Longitudinal study in 6,497 participants of the 1995 and 1998 Scottish health surveys, who were followed-up until 2011. Cox regression models were conducted adjusting for age, sex\/menopausal status, fibrinogen, GGT levels, smoking, alcohol consumption, total cholesterol, HDL-cholesterol, blood pressure, and BMI. Ferritin was used as continuous (sex\/menopausal status-specific Z score) and categorical variable (sex\/menopausal status-specific quartiles, quintiles and sextiles).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>During follow-up, 4.9% of the participants developed T2D, 5.3% CHD, and 2.3% CEVD. By using ferritin quartiles, serum ferritin was positively associated with T2D, CHD and CEVD but only the association with T2D remained after adjustment for covariates [Quartile 4 v. 1: adjusted HR 95% CI 1.59 (1.10\u20132.34); P\u2009=\u20090.006]. When ferritin sextiles were used (6 v. 1), the ferritin-CEVD association became slightly stronger and significant [adjusted HR 95% CI 2.08 (1.09\u20133.94); P\u2009=\u20090.024].<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Iron stores relate differently to each CMD. Serum ferritin levels were positively and independently associated with incident T2D, and with incident CEVD if higher cut-off points for high ferritin levels were considered.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12933-022-01450-7","type":"journal-article","created":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T15:02:36Z","timestamp":1645023756000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Serum ferritin and incident cardiometabolic diseases in Scottish adults"],"prefix":"10.1186","volume":"21","author":[{"given":"Milton-Fabian","family":"Su\u00e1rez-Orteg\u00f3n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stela","family":"McLachlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7442-9323","authenticated-orcid":false,"given":"Jos\u00e9-Manuel","family":"Fernandez-Real","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomi-Pekka","family":"Tuomainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Aregbesola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah H.","family":"Wild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,16]]},"reference":[{"key":"1450_CR1","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1002\/dmrr.2394","volume":"29","author":"SK Kunutsor","year":"2013","unstructured":"Kunutsor SK, Apekey TA, Walley J, Kain K. Ferritin levels and risk of type 2 diabetes mellitus: an updated systematic review and meta-analysis of prospective evidence. Diabetes Metab Res Rev. 2013;29:308\u201318.","journal-title":"Diabetes Metab Res Rev"},{"key":"1450_CR2","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.atherosclerosis.2014.12.018","volume":"238","author":"S De Das","year":"2015","unstructured":"De Das S, Krishna S, Jethwa A. Iron status and its association with coronary heart disease: systematic review and meta-analysis of prospective studies. Atherosclerosis. 2015;238:296\u2013303.","journal-title":"Atherosclerosis"},{"key":"1450_CR3","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1007\/s00125-018-4796-7","volume":"62","author":"SH Read","year":"2019","unstructured":"Read SH, Fischbacher CM, Colhoun HM, Gasevic D, Kerssens JJ, et al. Trends in incidence and case fatality of acute myocardial infarction, angina and coronary revascularisation in people with and without type 2 diabetes in Scotland between 2006 and 2015. Diabetologia. 2019;62:418-25.","journal-title":"Diabetologia"},{"key":"1450_CR4","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1136\/heartjnl-2016-309573","volume":"102","author":"P Bhatnagar","year":"2016","unstructured":"Bhatnagar P, Wickramasinghe K, Wilkins E, Townsend N. Trends in the epidemiology of cardiovascular disease in the UK. Heart. 2016;102:1945\u201352.","journal-title":"Heart"},{"key":"1450_CR5","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1007\/s00125-016-4054-9","volume":"59","author":"SH Read","year":"2016","unstructured":"Read SH, Kerssens JJ, McAllister DA, Colhoun HM, Fischbacher CM, et al. Trends in type 2 diabetes incidence and mortality in Scotland between 2004 and 2013. Diabetologia. 2016;59:2106\u201313.","journal-title":"Diabetologia"},{"key":"1450_CR6","unstructured":"SCOTLAND S. Scottish health survey 1995."},{"key":"1450_CR7","unstructured":"Shaw A, McMunn A, Field J. Scottish health survey 1998. 2000."},{"key":"1450_CR8","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1093\/ije\/dyp155","volume":"39","author":"L Gray","year":"2010","unstructured":"Gray L, Batty GD, Craig P, Stewart C, Whyte B, et al. Cohort profile: the Scottish health surveys cohort: linkage of study participants to routinely collected records for mortality, hospital discharge, cancer and offspring birth characteristics in three nationwide studies. Int J Epidemiol. 2010;39:345\u201350.","journal-title":"Int J Epidemiol"},{"key":"1450_CR9","doi-asserted-by":"publisher","first-page":"e0196576","DOI":"10.1371\/journal.pone.0196576","volume":"13","author":"MN Garcia-Casal","year":"2018","unstructured":"Garcia-Casal MN, Pe\u00f1a-Rosas JP, Urrechaga E, Escanero JF, Huo J, et al. Performance and comparability of laboratory methods for measuring ferritin concentrations in human serum or plasma: a systematic review and meta-analysis. PLoS ONE. 2018;13:e0196576.","journal-title":"PLoS ONE"},{"key":"1450_CR10","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1161\/CIRCULATIONAHA.108.804146","volume":"118","author":"A Langsted","year":"2008","unstructured":"Langsted A, Freiberg JJ, Nordestgaard BG. Fasting and nonfasting lipid levels: influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction. Circulation. 2008;118:2047\u201356.","journal-title":"Circulation"},{"key":"1450_CR11","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1161\/01.CIR.96.1.308","volume":"96","author":"SS Franklin","year":"1997","unstructured":"Franklin SS, Gustin Wt, Wong ND, Larson MG, Weber MA, Kannel WB, et al. Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation. 1997;96:308\u201315.","journal-title":"Circulation"},{"key":"1450_CR12","volume-title":"Anthropometric standardization reference manual","author":"TG Lohman","year":"1988","unstructured":"Lohman TG, Roche AF, Martorell R. Anthropometric standardization reference manual. Champaign: Human Kinetics Books; 1988."},{"key":"1450_CR13","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/0021-9681(72)90027-6","volume":"25","author":"A Keys","year":"1972","unstructured":"Keys A, Fidanza F, Karvonen MJ, Kimura N, Taylor HL. Indices of relative weight and obesity. J Chronic Dis. 1972;25:329\u201343.","journal-title":"J Chronic Dis"},{"key":"1450_CR14","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1249\/00003677-198600140-00014","volume":"14","author":"TG Lohman","year":"1986","unstructured":"Lohman TG. Applicability of body composition techniques and constants for children and youths. Exerc Sport Sci Rev. 1986;14:325\u201357.","journal-title":"Exerc Sport Sci Rev"},{"key":"1450_CR15","unstructured":"Organization WH. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. 2011."},{"key":"1450_CR16","unstructured":"Council S. Health Education Authority. (1992). Allied Dunbar National Fitness Survey London: Sports Council\/HEA. 1996."},{"key":"1450_CR17","unstructured":"Organization WH. International statistical classification of diseases and related health problems: World Health Organization; 2004."},{"key":"1450_CR18","doi-asserted-by":"crossref","unstructured":"Lunneborg CE. Jonckheere\u2013Terpstra Test. Wiley StatsRef: Statistics Reference Online. 2005.","DOI":"10.1002\/0470013192.bsa324"},{"key":"1450_CR19","doi-asserted-by":"publisher","first-page":"2670","DOI":"10.1093\/ndt\/gft355","volume":"28","author":"M Noordzij","year":"2013","unstructured":"Noordzij M, Leffondr\u00e9 K, van Stralen KJ, Zoccali C, Dekker FW, Jager KJ. When do we need competing risks methods for survival analysis in nephrology? Nephrol Dial Transplant. 2013;28:2670\u20137.","journal-title":"Nephrol Dial Transplant"},{"key":"1450_CR20","doi-asserted-by":"crossref","unstructured":"Harrell FE. Regression modeling strategies, with applications to linear models, survival analysis and logistic regression. Springer. http:\/\/www.biostatmcvanderbiltedu\/twiki\/bin\/view\/Main\/RmS, i SBN 0-387-95232-2. 2001.","DOI":"10.1007\/978-1-4757-3462-1"},{"key":"1450_CR21","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1093\/aje\/kwk093","volume":"165","author":"ML Jehn","year":"2007","unstructured":"Jehn ML, Guallar E, Clark JM, Couper D, Duncan BB, et al. A prospective study of plasma ferritin level and incident diabetes: the atherosclerosis risk in communities (ARIC) Study. Am J Epidemiol. 2007;165:1047\u201354.","journal-title":"Am J Epidemiol"},{"key":"1450_CR22","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1111\/jdi.12617","volume":"8","author":"S Akter","year":"2017","unstructured":"Akter S, Nanri A, Kuwahara K, Matsushita Y, Nakagawa T, et al. Circulating ferritin concentrations and risk of type 2 diabetes in Japanese individuals. J Diabetes Invest. 2017;8:462\u201370.","journal-title":"J Diabetes Invest"},{"key":"1450_CR23","doi-asserted-by":"publisher","first-page":"572","DOI":"10.2337\/dc15-0257","volume":"39","author":"C Podmore","year":"2016","unstructured":"Podmore C, Meidtner K, Schulze MB, Scott RA, Ramond A, et al. Association of multiple biomarkers of iron metabolism and type 2 diabetes: the EPIC-InterAct study. Diabetes Care. 2016;39:572\u201381.","journal-title":"Diabetes Care"},{"key":"1450_CR24","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1161\/01.STR.0000173172.82880.72","volume":"36","author":"AD Van der","year":"2005","unstructured":"Van der AD, Grobbee DE, Roest M, Marx JJ, Voorbij HA, et al. Serum ferritin is a risk factor for stroke in postmenopausal women. Stroke. 2005;36:1637\u201341.","journal-title":"Stroke"},{"key":"1450_CR25","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1093\/aje\/kwg121","volume":"158","author":"MW Knuiman","year":"2003","unstructured":"Knuiman MW, Divitini ML, Olynyk JK, Cullen DJ, Bartholomew HC. Serum ferritin and cardiovascular disease: a 17-year follow-up study in Busselton, Western Australia. Am J Epidemiol. 2003;158:144\u20139.","journal-title":"Am J Epidemiol"},{"key":"1450_CR26","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jff.2013.12.006","volume":"6","author":"P Scicchitano","year":"2014","unstructured":"Scicchitano P, Cameli M, Maiello M, Modesti PA, Muiesan ML, Novo S, Palmiero P, Saba PS, Pedrinelli R, Ciccone MM, di Studio IG. Nutraceuticals and dyslipidaemia: beyond the common therapeutics. J Funct Foods. 2014;6:11\u201332.","journal-title":"Funct Foods"},{"key":"1450_CR27","doi-asserted-by":"publisher","first-page":"g1088","DOI":"10.1136\/bmj.g1088","volume":"348","author":"JW Hotchkiss","year":"2014","unstructured":"Hotchkiss JW, Davies CA, Dundas R, Hawkins N, Jhund PS, et al. Explaining trends in Scottish coronary heart disease mortality between 2000 and 2010 using IMPACTSEC model: retrospective analysis using routine data. BMJ. 2014;348:g1088.","journal-title":"BMJ"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-022-01450-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-022-01450-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-022-01450-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T15:05:07Z","timestamp":1645023907000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-022-01450-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,16]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1450"],"URL":"https:\/\/doi.org\/10.1186\/s12933-022-01450-7","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,16]]},"assertion":[{"value":"27 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The secondary analysis of the SHeS-linked dataset was approved by the Ethics Research Subgroup of the Centre for Population Health Sciences of the University of Edinburgh.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"26"}}